Takeshi Toyoda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Takeshi Toyoda has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
Kumiko Ogawa
Division of Pathology, National Institute of Health Sciences, Kawasaki, Japan
23 shared publicationsTomomi Morikawa
Division of Pathology National Institute of Health Sciences Kawasaki Kanagawa Japan
22 shared publicationsKohei Matsushita
Division of Pathology, Center for Biological Safety and Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan
17 shared publications- Kumiko Ogawa
Division of Pathology National Institute of Health Sciences Kawasaki Kanagawa Japan
14 shared publications Hirotoshi Akane
Division of Pathology, National Institute of Health Sciences, Kawasaki, Japan
12 shared publicationsYasuko Mizuta
Division of Pathology National Institute of Health Sciences Kawasaki Kanagawa Japan
12 shared publications
Latest Publications
- 16 November 2026
- Published by Wiley in Journal of Applied Toxicology
Early Detection of Renal Carcinogens in Rats by Immunohistochemistry for γ‐H2AX
For safety evaluations of chemical substances, short‐term methods to replace long‐term carcinogenicity studies involving large numbers of animals are urgently needed. We have formerly demonstrated that γ‐H2AX, a well‐established marker of DNA damage, enables the early detection of urinary bladder carcinogens in rats with superior sensitivity and specificity. To determine whether this method using γ‐H2AX as an indicator can be applied to the kidney, we examined γ‐H2AX formation in the kidneys of rats that had received oral administration of renal or nonrenal carcinogens for 28 days. Among the 47 compounds examined, significant increases in the ratio of γ‐H2AX‐positive tubular epithelial cells were induced by 22/26 of renal carcinogens (sensitivity; 84.6%) but only 1/21 of nonrenal carcinogens (specificity; 95.2%). γ‐H2AX formation was increased by both Ames‐positive and Ames‐negative renal carcinogens, suggesting that this method can also detect secondary DNA damage following cell injury and proliferative stimulation. Moreover, γ‐H2AX formation in tubular epithelial cells showed clear time‐ and dose‐dependencies and was detected for five renal carcinogens that did not induce histopathological changes in the kidneys. This result demonstrates the high performance of this method for screening of renal carcinogenicity. This method can be implemented simply by adding conventional immunostaining of formalin‐fixed, paraffin‐embedded tissues to the 28‐day repeated‐dose toxicity study in rats that is commonly conducted for safety evaluation of chemicals. Combined with examination of the bladder, this method could be used to comprehensively evaluate carcinogenicity in the urinary system within a short timeframe.
- 16 November 2026
- Published by Wiley in Journal of Applied Toxicology
Early Detection of Renal Carcinogens in Rats by Immunohistochemistry for γ‐H2AX
For safety evaluations of chemical substances, short‐term methods to replace long‐term carcinogenicity studies involving large numbers of animals are urgently needed. We have formerly demonstrated that γ‐H2AX, a well‐established marker of DNA damage, enables the early detection of urinary bladder carcinogens in rats with superior sensitivity and specificity. To determine whether this method using γ‐H2AX as an indicator can be applied to the kidney, we examined γ‐H2AX formation in the kidneys of rats that had received oral administration of renal or nonrenal carcinogens for 28 days. Among the 47 compounds examined, significant increases in the ratio of γ‐H2AX‐positive tubular epithelial cells were induced by 22/26 of renal carcinogens (sensitivity; 84.6%) but only 1/21 of nonrenal carcinogens (specificity; 95.2%). γ‐H2AX formation was increased by both Ames‐positive and Ames‐negative renal carcinogens, suggesting that this method can also detect secondary DNA damage following cell injury and proliferative stimulation. Moreover, γ‐H2AX formation in tubular epithelial cells showed clear time‐ and dose‐dependencies and was detected for five renal carcinogens that did not induce histopathological changes in the kidneys. This result demonstrates the high performance of this method for screening of renal carcinogenicity. This method can be implemented simply by adding conventional immunostaining of formalin‐fixed, paraffin‐embedded tissues to the 28‐day repeated‐dose toxicity study in rats that is commonly conducted for safety evaluation of chemicals. Combined with examination of the bladder, this method could be used to comprehensively evaluate carcinogenicity in the urinary system within a short timeframe.
- 6 October 2026
- Published by Wiley in Journal of Applied Toxicology
Comparison of the Sensitivity of Histopathological and Immunohistochemical Analyses With That of Serum Hormone Measurements for Early Detection of Antithyroid Effects in Rats Treated With Iodide Uptake Inhibitors
Serum thyroxine (T4), triiodothyronine (T3), and thyroid‐stimulating hormone (TSH) measurements are widely used to detect antithyroid effects in rodent toxicity studies. However, the assays used to measure these hormones are costly and highly variable depending on the blood sampling and measurement conditions. We previously demonstrated that histopathological evaluation detects the effects of thyroid peroxidase (TPO) inhibitors and thyroid hormone metabolism promoters more sensitively than serum hormone measurements. Here, we examined whether this approach can also improve early detection of antithyroid chemicals that inhibit iodide uptake, an essential step in thyroid hormone synthesis. We compared histopathological and immunohistochemical findings with serum hormone measurements in 6‐week‐old male Sprague–Dawley rats (five per group) administered ammonium perchlorate (APC) or potassium thiocyanate (PTC) in drinking water for 28 days. Serum T4 decreased at 1000 ppm APC and 5000 ppm PTC, T3 decreased at 1000 ppm APC, and TSH increased at ≥ 100 ppm APC. In contrast, follicular cell hypertrophy was detected at ≥ 10 ppm APC and 5000 ppm PTC, indicating greater sensitivity compared with serum hormone measurements. Decreased T3 and T4 immunostaining showed a sensitivity comparable with that of serum hormone changes, whereas thyroid sodium/iodide symporter (NIS)‐immunopositive areas increased at doses that produced no detectable changes in serum hormone levels, suggesting that NIS immunostaining represents the most sensitive marker of iodide uptake inhibition. These results suggest that combining histopathological and immunohistochemical analyses enables sensitive detection of antithyroid effects and provides mechanistic information that cannot be obtained from serum hormone measurements alone.
- 6 October 2026
- Published by Wiley in Journal of Applied Toxicology
Comparison of the Sensitivity of Histopathological and Immunohistochemical Analyses With That of Serum Hormone Measurements for Early Detection of Antithyroid Effects in Rats Treated With Iodide Uptake Inhibitors
Serum thyroxine (T4), triiodothyronine (T3), and thyroid‐stimulating hormone (TSH) measurements are widely used to detect antithyroid effects in rodent toxicity studies. However, the assays used to measure these hormones are costly and highly variable depending on the blood sampling and measurement conditions. We previously demonstrated that histopathological evaluation detects the effects of thyroid peroxidase (TPO) inhibitors and thyroid hormone metabolism promoters more sensitively than serum hormone measurements. Here, we examined whether this approach can also improve early detection of antithyroid chemicals that inhibit iodide uptake, an essential step in thyroid hormone synthesis. We compared histopathological and immunohistochemical findings with serum hormone measurements in 6‐week‐old male Sprague–Dawley rats (five per group) administered ammonium perchlorate (APC) or potassium thiocyanate (PTC) in drinking water for 28 days. Serum T4 decreased at 1000 ppm APC and 5000 ppm PTC, T3 decreased at 1000 ppm APC, and TSH increased at ≥ 100 ppm APC. In contrast, follicular cell hypertrophy was detected at ≥ 10 ppm APC and 5000 ppm PTC, indicating greater sensitivity compared with serum hormone measurements. Decreased T3 and T4 immunostaining showed a sensitivity comparable with that of serum hormone changes, whereas thyroid sodium/iodide symporter (NIS)‐immunopositive areas increased at doses that produced no detectable changes in serum hormone levels, suggesting that NIS immunostaining represents the most sensitive marker of iodide uptake inhibition. These results suggest that combining histopathological and immunohistochemical analyses enables sensitive detection of antithyroid effects and provides mechanistic information that cannot be obtained from serum hormone measurements alone.
- 13 March 2025
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 53 (3) , 251-266
Comparisons of the Sensitivity of Histopathological and Immunohistochemical Analyses With Blood Hormone Levels for Early Detection of Antithyroid Effects in Rats Treated With Promoters of Thyroid Hormone Metabolism
Although blood triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH) levels are useful for detecting antithyroid compounds in rodent toxicity studies, there are challenges with high variability due to sampling conditions. Here, we compared histopathological and immunohistochemical findings with blood hormone levels in rats treated with promoters of thyroid hormone metabolism to explore useful markers for hypothyroidism. Six-week-old male and female Sprague-Dawley rats (5/group) were administered phenobarbital sodium salt (NaPB) or nicardipine hydrochloride (NCD) by gavage for 28 days. Decreased serum T4 and increased TSH levels were detected at 100 mg/kg NaPB and 150 mg/kg NCD, whereas follicular cell hypertrophy occurred at lower doses of ≥ 30 mg/kg NaPB and ≥ 50 mg/kg NCD. There was no obvious change in T3 or T4 immunostaining in the thyroid unlike thyroid peroxidase (TPO) inhibitors, and uridine diphosphate-glucuronosyltransferase 1A6-positive area in the liver increased at doses lower than those affecting the serum T4 levels and generally the same as those at which hepatocellular hypertrophy and follicular cell hypertrophy were observed, indicating its usefulness in detecting thyroid hormone metabolism promoters. These results indicate that histopathology is useful for sensitive detection of hormone metabolism promoters and can be distinguished from TPO inhibitors by immunohistochemistry.
- 13 March 2025
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 53 (3) , 251-266
Comparisons of the Sensitivity of Histopathological and Immunohistochemical Analyses With Blood Hormone Levels for Early Detection of Antithyroid Effects in Rats Treated With Promoters of Thyroid Hormone Metabolism
Although blood triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH) levels are useful for detecting antithyroid compounds in rodent toxicity studies, there are challenges with high variability due to sampling conditions. Here, we compared histopathological and immunohistochemical findings with blood hormone levels in rats treated with promoters of thyroid hormone metabolism to explore useful markers for hypothyroidism. Six-week-old male and female Sprague-Dawley rats (5/group) were administered phenobarbital sodium salt (NaPB) or nicardipine hydrochloride (NCD) by gavage for 28 days. Decreased serum T4 and increased TSH levels were detected at 100 mg/kg NaPB and 150 mg/kg NCD, whereas follicular cell hypertrophy occurred at lower doses of ≥ 30 mg/kg NaPB and ≥ 50 mg/kg NCD. There was no obvious change in T3 or T4 immunostaining in the thyroid unlike thyroid peroxidase (TPO) inhibitors, and uridine diphosphate-glucuronosyltransferase 1A6-positive area in the liver increased at doses lower than those affecting the serum T4 levels and generally the same as those at which hepatocellular hypertrophy and follicular cell hypertrophy were observed, indicating its usefulness in detecting thyroid hormone metabolism promoters. These results indicate that histopathology is useful for sensitive detection of hormone metabolism promoters and can be distinguished from TPO inhibitors by immunohistochemistry.
- Open Access
- 1 January 2025
- Published by Japanese Society of Toxicologic Pathology in Journal of Toxicologic Pathology
- Vol. 38 (4) , 2025-0057-236
A 28-day subacute toxicity study of puberulic acid in Crl:CD(SD) rats
In March 2024, a health hazard associated with the consumption of food products containing red yeast rice (beni-koji), which could lead to renal dysfunction, was reported in Japan. Puberulic acid (PA) was identified as an unintentional contaminant in these products; however, information on PA toxicity remains limited. The toxicological profile of PA was evaluated in a 28-day subacute toxicity study in rats. Synthesized PA, was administrated by gavage to 6-week-old Crl:CD(SD) rats at 0, 1, 3, or 10 mg/kg/day (male) or 0, 0.3, 1, or 3 mg/kg/day (female) over 28 days, and satellite groups were used to evaluate the reversibility over a 14-day period. Male rats in the 10 mg/kg group exhibited increased urinary glucose and serum creatinine levels compared to controls. Histopathological examination revealed vacuolation, necrosis, and regeneration of proximal tubules in kidneys of all rats in the male 10 mg/kg and female 3 mg/kg groups. After the 14-day recovery period, focal interstitial fibrosis was observed in one male rats from the high-dose group, whereas no renal lesions were detected in the remaining rats of either sex. These results suggest that PA-induced nephrotoxicity is largely reversible under the conditions studied, although residual chronic lesions may occur in severe cases. Apoptosis/necrosis and diffuse hyperplasia of the glandular stomach mucosa were observed in male 3 and 10 mg/kg and female 3 mg/kg groups but were absent after the recovery period. These results indicate that, under the study conditions, the no-observed-adverse-effect level for PA was 1 mg/kg/day for both sexes.
- 1 January 2025
- Published by Japanese Society of Toxicologic Pathology in Journal of Toxicologic Pathology
- Vol. 38 (4) , 2025-0057-236
Open AccessA 28-day subacute toxicity study of puberulic acid in Crl:CD(SD) rats
In March 2024, a health hazard associated with the consumption of food products containing red yeast rice (beni-koji), which could lead to renal dysfunction, was reported in Japan. Puberulic acid (PA) was identified as an unintentional contaminant in these products; however, information on PA toxicity remains limited. The toxicological profile of PA was evaluated in a 28-day subacute toxicity study in rats. Synthesized PA, was administrated by gavage to 6-week-old Crl:CD(SD) rats at 0, 1, 3, or 10 mg/kg/day (male) or 0, 0.3, 1, or 3 mg/kg/day (female) over 28 days, and satellite groups were used to evaluate the reversibility over a 14-day period. Male rats in the 10 mg/kg group exhibited increased urinary glucose and serum creatinine levels compared to controls. Histopathological examination revealed vacuolation, necrosis, and regeneration of proximal tubules in kidneys of all rats in the male 10 mg/kg and female 3 mg/kg groups. After the 14-day recovery period, focal interstitial fibrosis was observed in one male rats from the high-dose group, whereas no renal lesions were detected in the remaining rats of either sex. These results suggest that PA-induced nephrotoxicity is largely reversible under the conditions studied, although residual chronic lesions may occur in severe cases. Apoptosis/necrosis and diffuse hyperplasia of the glandular stomach mucosa were observed in male 3 and 10 mg/kg and female 3 mg/kg groups but were absent after the recovery period. These results indicate that, under the study conditions, the no-observed-adverse-effect level for PA was 1 mg/kg/day for both sexes.
- 2 April 2024
- Published by Wiley in Journal of Applied Toxicology
- Vol. 44 (7) , 1084-1103
Comparison of the sensitivity of histopathological and immunohistochemical analyses and blood hormone levels for early detection of antithyroid effects in rats treated with thyroid peroxidase inhibitors
Although measurements of blood triiodothyronine (T3), thyroxine (T4), and thyroid‐stimulating hormone (TSH) levels in rodent toxicity studies are useful for detection of antithyroid substances, assays for these measurements are expensive and can show high variability depending on blood sampling conditions. To develop more efficient methods for detecting thyroid disruptors, we compared histopathological and immunohistochemical findings in the thyroid and pituitary glands with blood hormone levels. Six‐week‐old male and female Sprague–Dawley rats (five rats per group) were treated with multiple doses of the thyroid peroxidase inhibitors propylthiouracil (PTU) and methimazole by gavage for 28 days. Significant decreases in serum T3 and T4 and increases in TSH were observed in the ≥1 mg/kg PTU and ≥3 mg/kg methimazole groups. An increase in TSH was also detected in male rats in the 0.3 mg/kg PTU group. Histopathological and immunohistochemical analyses revealed that follicular cell hypertrophy and decreased T4 and T3 expressions in the thyroid gland were induced at doses lower than doses at which significant changes in serum hormone levels were observed, suggesting that these findings may be more sensitive than blood hormone levels. Significant increases in thyroid weights, Ki67‐positive thyroid follicular cell counts, and TSH‐positive areas in the pituitary gland were detected at doses comparable with those at which changes in serum T4 and TSH levels were observed, indicating that these parameters may also be useful for evaluation of antithyroid effects. Combining these parameters may be effective for detecting antithyroid substances without relying on hormone measurements.
- 2 April 2024
- Published by Wiley in Journal of Applied Toxicology
- Vol. 44 (7) , 1084-1103
Comparison of the sensitivity of histopathological and immunohistochemical analyses and blood hormone levels for early detection of antithyroid effects in rats treated with thyroid peroxidase inhibitors
Although measurements of blood triiodothyronine (T3), thyroxine (T4), and thyroid‐stimulating hormone (TSH) levels in rodent toxicity studies are useful for detection of antithyroid substances, assays for these measurements are expensive and can show high variability depending on blood sampling conditions. To develop more efficient methods for detecting thyroid disruptors, we compared histopathological and immunohistochemical findings in the thyroid and pituitary glands with blood hormone levels. Six‐week‐old male and female Sprague–Dawley rats (five rats per group) were treated with multiple doses of the thyroid peroxidase inhibitors propylthiouracil (PTU) and methimazole by gavage for 28 days. Significant decreases in serum T3 and T4 and increases in TSH were observed in the ≥1 mg/kg PTU and ≥3 mg/kg methimazole groups. An increase in TSH was also detected in male rats in the 0.3 mg/kg PTU group. Histopathological and immunohistochemical analyses revealed that follicular cell hypertrophy and decreased T4 and T3 expressions in the thyroid gland were induced at doses lower than doses at which significant changes in serum hormone levels were observed, suggesting that these findings may be more sensitive than blood hormone levels. Significant increases in thyroid weights, Ki67‐positive thyroid follicular cell counts, and TSH‐positive areas in the pituitary gland were detected at doses comparable with those at which changes in serum T4 and TSH levels were observed, indicating that these parameters may also be useful for evaluation of antithyroid effects. Combining these parameters may be effective for detecting antithyroid substances without relying on hormone measurements.
- Open Access
- 1 January 2024
- Published by Japanese Society of Toxicologic Pathology in Journal of Toxicologic Pathology
- Vol. 37 (4) , 151-161
A 13-week subchronic toxicity study of linalool oxide in Crl:CD(SD) rats
Linalool oxide is frequently used as a flavoring agent, however, data on its toxicity is limited. In this study, we performed a 13-week subchronic toxicity study of linalool oxide (furanoid) in male and female Crl:CD(SD) rats. Doses of 0, 80, 250, and 800 mg/kg body weight (bw) per day were orally administered by gavage, using corn oil as the vehicle. Abnormal gait in both sexes and decreased locomotor activity in males were observed in the 800 mg/kg group. Reduced body weight gain was noted in both sexes at 800 mg/kg and at 250 mg/kg in males. In the 800 mg/kg group, serum biochemistry showed increased gamma-glutamyl transpeptidase and decreased glucose in both sexes, increased total protein in males, and increased total cholesterol and phospholipids in females, suggesting that linalool oxide may have adverse effects on the liver. Increased relative and/or absolute liver weights, centrilobular hepatocellular hypertrophy in both sexes, and periportal microvesicular fatty changes in females were observed in the 800 mg/kg group. Increased relative liver weights and decreased serum glucose levels were observed in the 250 mg/kg male and female groups, respectively. Increased serum magnesium levels and relative kidney weights were observed in both sexes in the 800 mg/kg group, suggesting possible adverse effects of linalool oxide. Although histopathology showed accumulation of hyaline droplets in the male kidneys, immunohistochemistry revealed alpha 2u-globulin 2u-globulin nephropathy, which was not considered toxicologically significant. These results indicate that the no-observed-adverse-effect level of linalool oxide was 80 mg/kg bw/day for both sexes. (DOI: 10.1293/tox.2024-0012; J Toxicol Pathol 2024; 37: 151-161)
- 1 January 2024
- Published by Japanese Society of Toxicologic Pathology in Journal of Toxicologic Pathology
- Vol. 37 (4) , 151-161
Open AccessA 13-week subchronic toxicity study of linalool oxide in Crl:CD(SD) rats
Linalool oxide is frequently used as a flavoring agent, however, data on its toxicity is limited. In this study, we performed a 13-week subchronic toxicity study of linalool oxide (furanoid) in male and female Crl:CD(SD) rats. Doses of 0, 80, 250, and 800 mg/kg body weight (bw) per day were orally administered by gavage, using corn oil as the vehicle. Abnormal gait in both sexes and decreased locomotor activity in males were observed in the 800 mg/kg group. Reduced body weight gain was noted in both sexes at 800 mg/kg and at 250 mg/kg in males. In the 800 mg/kg group, serum biochemistry showed increased gamma-glutamyl transpeptidase and decreased glucose in both sexes, increased total protein in males, and increased total cholesterol and phospholipids in females, suggesting that linalool oxide may have adverse effects on the liver. Increased relative and/or absolute liver weights, centrilobular hepatocellular hypertrophy in both sexes, and periportal microvesicular fatty changes in females were observed in the 800 mg/kg group. Increased relative liver weights and decreased serum glucose levels were observed in the 250 mg/kg male and female groups, respectively. Increased serum magnesium levels and relative kidney weights were observed in both sexes in the 800 mg/kg group, suggesting possible adverse effects of linalool oxide. Although histopathology showed accumulation of hyaline droplets in the male kidneys, immunohistochemistry revealed alpha 2u-globulin 2u-globulin nephropathy, which was not considered toxicologically significant. These results indicate that the no-observed-adverse-effect level of linalool oxide was 80 mg/kg bw/day for both sexes. (DOI: 10.1293/tox.2024-0012; J Toxicol Pathol 2024; 37: 151-161)
- 24 October 2023
- Published by Wiley in Journal of Applied Toxicology
- Vol. 44 (3) , 455-469
Role of CD44 expressed in renal tubules during maladaptive repair in renal fibrogenesis in an allopurinol‐induced rat model of chronic kidney disease
The kidney is a major target organ for the adverse effects of pharmaceuticals; renal tubular epithelial cells (TECs) are particularly vulnerable to drug‐induced toxicity. TECs have regenerative capacity; however, maladaptive repair of TECs after injury leads to renal fibrosis, resulting in chronic kidney disease (CKD). We previously reported the specific expression of CD44 in failed‐repair TECs of rat CKD model induced by ischemia reperfusion injury. Here, we investigated the pathophysiological role of CD44 in renal fibrogenesis in allopurinol‐treated rat CKD model. Dilated or atrophic TECs expressing CD44 in fibrotic areas were collected by laser microdissection and subjected to microarray analysis. Gene ontology showed that extracellular matrix (ECM)‐related genes were upregulated and differentiation‐related genes were downregulated in dilated/atrophic TECs. Ingenuity Pathway Analysis identified CD44 as an upstream regulator of fibrosis‐related genes, including Fn1, which encodes fibronectin. Immunohistochemistry demonstrated that dilated/atrophic TECs expressing CD44 showed decreases in differentiation markers of TECs and clear expression of mesenchymal markers during basement membrane attachment. In situ hybridization revealed an increase in Fn1 mRNA in the cytoplasm of dilated/atrophic TECs, whereas fibronectin was localized in the stroma around these TECs, supporting the production/secretion of ECM by dilated/atrophic TECs. Overall, these data indicated that dilated/atrophic TECs underwent a partial epithelial–mesenchymal transition (pEMT) and that CD44 promoted renal fibrogenesis via induction of ECM production in failed‐repair TECs exhibiting pEMT. CD44 was detected in the urine and serum of APL‐treated rats, which may reflect the expression of CD44 in the kidney.
- 24 October 2023
- Published by Wiley in Journal of Applied Toxicology
- Vol. 44 (3) , 455-469
Role of CD44 expressed in renal tubules during maladaptive repair in renal fibrogenesis in an allopurinol‐induced rat model of chronic kidney disease
The kidney is a major target organ for the adverse effects of pharmaceuticals; renal tubular epithelial cells (TECs) are particularly vulnerable to drug‐induced toxicity. TECs have regenerative capacity; however, maladaptive repair of TECs after injury leads to renal fibrosis, resulting in chronic kidney disease (CKD). We previously reported the specific expression of CD44 in failed‐repair TECs of rat CKD model induced by ischemia reperfusion injury. Here, we investigated the pathophysiological role of CD44 in renal fibrogenesis in allopurinol‐treated rat CKD model. Dilated or atrophic TECs expressing CD44 in fibrotic areas were collected by laser microdissection and subjected to microarray analysis. Gene ontology showed that extracellular matrix (ECM)‐related genes were upregulated and differentiation‐related genes were downregulated in dilated/atrophic TECs. Ingenuity Pathway Analysis identified CD44 as an upstream regulator of fibrosis‐related genes, including Fn1, which encodes fibronectin. Immunohistochemistry demonstrated that dilated/atrophic TECs expressing CD44 showed decreases in differentiation markers of TECs and clear expression of mesenchymal markers during basement membrane attachment. In situ hybridization revealed an increase in Fn1 mRNA in the cytoplasm of dilated/atrophic TECs, whereas fibronectin was localized in the stroma around these TECs, supporting the production/secretion of ECM by dilated/atrophic TECs. Overall, these data indicated that dilated/atrophic TECs underwent a partial epithelial–mesenchymal transition (pEMT) and that CD44 promoted renal fibrogenesis via induction of ECM production in failed‐repair TECs exhibiting pEMT. CD44 was detected in the urine and serum of APL‐treated rats, which may reflect the expression of CD44 in the kidney.
- Open Access
- 19 October 2023
- Published by Wiley in Cancer Science
- Vol. 114 (12) , 4763-4769
EpCAM and APN expression in combination with γ‐H2AX as biomarkers for detecting hepatocarcinogens in rats
The phosphorylated form of histone H2AX (gamma-H2AX) serves as a commonly utilized biomarker for DNA damage. Based on our previous findings, which demonstrated the formation of gamma-H2AX foci as a reliable biomarker for detecting bladder carcinogens in repeated dose 28-day study in rats, we hypothesized that gamma-H2AX could also function as a biomarker for detecting hepatocarcinogens. However, we found that gamma-H2AX foci formation was not effectively induced by hepatocarcinogens that did not stimulate hepatocyte proliferation. Therefore, we explored alternative biomarkers to detect chemical hepatocarcinogenicity and discovered increased expressions of epithelial cell adhesion molecule (EpCAM/CD326)- and aminopeptidase N (APN/CD13) in the hepatocytes of rats administered various hepatocarcinogens. Significant increases in EpCAM- and APN-positive hepatocytes were observed for eight and five of the 10 hepatocarcinogens, respectively. Notably, five and two of them, respectively, were negative for gamma-H2AX foci. These results highlight the potential of EpCAM and APN as useful biomarkers in combination with gamma-H2AX for the detection of chemical hepatocarcinogenicity.
- 19 October 2023
- Published by Wiley in Cancer Science
- Vol. 114 (12) , 4763-4769
Open AccessEpCAM and APN expression in combination with γ‐H2AX as biomarkers for detecting hepatocarcinogens in rats
The phosphorylated form of histone H2AX (gamma-H2AX) serves as a commonly utilized biomarker for DNA damage. Based on our previous findings, which demonstrated the formation of gamma-H2AX foci as a reliable biomarker for detecting bladder carcinogens in repeated dose 28-day study in rats, we hypothesized that gamma-H2AX could also function as a biomarker for detecting hepatocarcinogens. However, we found that gamma-H2AX foci formation was not effectively induced by hepatocarcinogens that did not stimulate hepatocyte proliferation. Therefore, we explored alternative biomarkers to detect chemical hepatocarcinogenicity and discovered increased expressions of epithelial cell adhesion molecule (EpCAM/CD326)- and aminopeptidase N (APN/CD13) in the hepatocytes of rats administered various hepatocarcinogens. Significant increases in EpCAM- and APN-positive hepatocytes were observed for eight and five of the 10 hepatocarcinogens, respectively. Notably, five and two of them, respectively, were negative for gamma-H2AX foci. These results highlight the potential of EpCAM and APN as useful biomarkers in combination with gamma-H2AX for the detection of chemical hepatocarcinogenicity.
- 29 September 2023
- Published by Springer Nature in Archives of Toxicology
- Vol. 97 (12) , 3197-3207
Mucosal damage and γ-H2AX formation in the rat urinary bladder induced by aromatic amines with structures similar to o-toluidine and o-anisidine
Although aromatic amines are widely used as raw materials for dyes, some, such as o-toluidine and o-anisidine, have shown concerning results regarding carcinogenicity in the urinary bladder. We have recently developed a short-term detection method for bladder carcinogens using immunohistochemistry for γ-H2AX, a DNA damage marker. Here, using this method, we evaluated aromatic amines with structures similar to o-toluidine and o-anisidine for bladder mucosal damage and potential carcinogenicity. In total, 17 aromatic amines were orally administered to male F344 rats for 28 days, and histopathological examination and γ-H2AX immunostaining of the urinary bladder were performed. Histopathological analysis revealed that seven aromatic amines, including 4-chloro-o-toluidine (4-CT), o-aminoazotoluene, 2-aminobenzyl alcohol (ABA), o-acetotoluidine (o-AT), 3,3ʹ-dimethoxybenzidine, 4-aminoazobenzene (AAB), and 4,4′-methylenedianiline (MDA), induced various bladder lesions, such as hemorrhage, necrosis, and urothelial hyperplasia. The morphological characteristics of mucosal damage induced by these substances were divided into two major types: those resembling o-toluidine and those resembling o-anisidine. Six of these aromatic amines, excluding MDA, also caused significant increases in γ-H2AX formation in the bladder urothelium. Interestingly, 4-CT did not cause mucosal damage or γ-H2AX formation at the lower dose applied in previous carcinogenicity studies. These results showed for the first time that o-AT and ABA, metabolites of o-toluidine, as well as AAB caused damage to the bladder mucosa and suggested that they may be bladder carcinogens. In addition, 4-CT, which was thought to be a noncarcinogen, was found to exhibit bladder toxicity upon exposure to high doses, indicating that this compound may contribute to bladder carcinogenesis.
- 29 September 2023
- Published by Springer Nature in Archives of Toxicology
- Vol. 97 (12) , 3197-3207
Mucosal damage and γ-H2AX formation in the rat urinary bladder induced by aromatic amines with structures similar to o-toluidine and o-anisidine
Although aromatic amines are widely used as raw materials for dyes, some, such as o-toluidine and o-anisidine, have shown concerning results regarding carcinogenicity in the urinary bladder. We have recently developed a short-term detection method for bladder carcinogens using immunohistochemistry for γ-H2AX, a DNA damage marker. Here, using this method, we evaluated aromatic amines with structures similar to o-toluidine and o-anisidine for bladder mucosal damage and potential carcinogenicity. In total, 17 aromatic amines were orally administered to male F344 rats for 28 days, and histopathological examination and γ-H2AX immunostaining of the urinary bladder were performed. Histopathological analysis revealed that seven aromatic amines, including 4-chloro-o-toluidine (4-CT), o-aminoazotoluene, 2-aminobenzyl alcohol (ABA), o-acetotoluidine (o-AT), 3,3ʹ-dimethoxybenzidine, 4-aminoazobenzene (AAB), and 4,4′-methylenedianiline (MDA), induced various bladder lesions, such as hemorrhage, necrosis, and urothelial hyperplasia. The morphological characteristics of mucosal damage induced by these substances were divided into two major types: those resembling o-toluidine and those resembling o-anisidine. Six of these aromatic amines, excluding MDA, also caused significant increases in γ-H2AX formation in the bladder urothelium. Interestingly, 4-CT did not cause mucosal damage or γ-H2AX formation at the lower dose applied in previous carcinogenicity studies. These results showed for the first time that o-AT and ABA, metabolites of o-toluidine, as well as AAB caused damage to the bladder mucosa and suggested that they may be bladder carcinogens. In addition, 4-CT, which was thought to be a noncarcinogen, was found to exhibit bladder toxicity upon exposure to high doses, indicating that this compound may contribute to bladder carcinogenesis.
- 3 March 2023
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 175, 113702
A 13-week subchronic toxicity study of heme iron in SD rats
- 3 March 2023
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 175, 113702
A 13-week subchronic toxicity study of heme iron in SD rats